Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Abdominal pain and hypertension in a 55-year-old male patient].

Der Internist·2016

Same author

Interleukin-1 antagonism in type 1 diabetes of long duration.

Diabetes & metabolism·2016

Same author

Targeting inflammation in the treatment of type 2 diabetes.

Diabetes, obesity & metabolism·2013

Same author

Effect of psychological stress on glucose control in patients with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2011

Same author

Hypercholesterolaemia, signs of islet microangiopathy and altered angiogenesis precede onset of type 2 diabetes in the Goto-Kakizaki (GK) rat.

Diabetologia·2011

Same author

Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet.

Diabetologia·2010

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Lepr^db Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Insulitis in type 2 diabetes.

M Böni-Schnetzler¹, J A Ehses, M Faulenbach

¹Clinic of Endocrinology and Diabetes and Centre for Integrated Human Physiology, University Hospital of Zurich, Zurich, Switzerland.

Diabetes, Obesity & Metabolism

|October 18, 2008

Summary

This summary is machine-generated.

Inflammation, marked by interleukin-1 beta and macrophages, is key in type 2 diabetes islets. Targeting these inflammatory factors may offer a disease-modifying therapy for type 2 diabetes.

More Related Videos

Isolation of Human Islets from Partially Pancreatectomized Patients

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Related Experiment Videos

Last Updated: Jun 29, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Lepr^db Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Isolation of Human Islets from Partially Pancreatectomized Patients

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Area of Science:

Endocrinology
Immunology
Pathology

Background:

Type 2 diabetes is characterized by islet inflammation, including cytokines, immune cells, beta-cell apoptosis, amyloid deposits, and fibrosis.
Beta-cells in type 2 diabetes exhibit inflammatory markers, notably elevated interleukin-1 beta (IL-1 beta) expression.
Increased islet-associated macrophages are present in human type 2 diabetic patients and animal models, appearing early before disease onset.

Purpose of the Study:

To investigate the role of intra-islet inflammation in type 2 diabetes pathogenesis.
To explore the potential of modulating inflammatory mediators, specifically IL-1 beta, as a therapeutic strategy.

Main Methods:

Analysis of islet characteristics in type 2 diabetes patients and animal models.
Assessment of inflammatory markers, including IL-1 beta and macrophage presence.
Investigation of chemokine-mediated immune cell attraction.

Main Results:

Islets in type 2 diabetes exhibit significant inflammatory features.
Elevated IL-1 beta expression and increased macrophage infiltration are observed in diabetic islets.
Macrophages are detected early in high-fat fed mice, suggesting a role prior to overt diabetes.

Conclusions:

Intra-islet inflammation, driven by factors like IL-1 beta and macrophages, is a critical component of type 2 diabetes.
Modulating intra-islet inflammatory mediators, particularly IL-1 beta, holds promise for preventing insulitis and offers a potential disease-modifying therapy for type 2 diabetes.